Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Particle Accelerators × Clear all

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Cyclophosphamide 352 Carboplatin 299 pembrolizumab 279 Gemcitabine 277 Cisplatin 277 Radiotherapy 261 Paclitaxel 259 Docetaxel 250 Bevacizumab 217 Rituximab 205 Capecitabine 197 Nivolumab 187 Fluorouracil 176 Dexamethasone 175 fludarabine 162 Oxaliplatin 155 Doxorubicin 138 Leucovorin 131 Irinotecan 130 Etoposide 129 Pemetrexed 126 Cytarabine 124 fludarabine phosphate 113 Bortezomib 113 Filgrastim 109 Lenalidomide 108 Cetuximab 106 Erlotinib Hydrochloride 105 Temozolomide 99 Radiation 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01700569 2023-02-21

FOLAGLI

Institut Cancerologie de l'Ouest

Phase 1 Terminated

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡